POTENTIAL IMMUNOMODULATORY EFFECT OF SINGLE AND COMBINED THERAPIES AGAINST CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MOUSE MODEL

Control of the Waterborne Cryptosporidiosis: Evaluation of the Protective Role of Cryptosporidium parvum Oocysts Antigen in Infected Immunocompetent and Immunosuppressed Mice

EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE

Effect of piperazine citrate on experimentally cryptosporidium parvum infected mice

EFFECT OF SOME MEDICINAL HERBS VERSUS NITAZOXANIDE ON CRYPTOSPORIDIUM PARVUM INFECTED IMMUNOSUPPRESSED MICE

Effect of Silver Nanoparticles loaded Nitazoxanide in The Treatment of Murine Cryptosporidiosis in Immunocompetent and Immunosuppressed Mice

PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS

PARASITOLOGICAL ASSESSMENT OF DIFFERENT CONCENTRATIONS OF PIPERAZINE CITRATE AGAINST CRYPTOSPORIDIOSIS INFECTION IN BOTH IMMUNOCOMPETENT AND IMMUNOCOMPROMISED MICE

Evaluation of the therapeutic effect of Zingiber Officinale loaded on nanoparticles for cryptosporidiosis in experimentally immunosuppressed mice

IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALING